Cystic Fibrosis News Today Forums Forums Science and Research Preclinical Data Shows That ELX-02 Increase CFTR Levels

  • Preclinical Data Shows That ELX-02 Increase CFTR Levels

    Posted by cystic-fibrosis-news-moderator on April 3, 2019 at 9:01 am

    At the 2019 European Cystic Fibrosis Society (ECFS) Basic Science Conference in March, Eloxx Pharmaceuticals presented new positive preclinical data for ELX-02, its lead treatment candidate for cystic fibrosis (CF), demonstrating that the therapy increases the levels of CFTR protein and its correct placement at the cell’s surface in patient-derived organoids. Click here to learn more.

    What are your thoughts on this news?

  • 0 Replies

Sorry, there were no replies found.

Log in to reply.